NCT02250092

Brief Summary

Hemiparetic cerebral palsy influences motor function in children during development and throughout their lifetime. The deficits one sees are the result both of the congenitally induced brain lesion and the subsequent plasticity that can impair function of the surviving neurons in the damaged brain. Many current treatments have limited influence on children's neurorecovery. Constraint-induced movement therapy (CIMT) involving constraining the unaffected limb to encourage use of the affected limb has shown promise, yet with new technology revealing the potential to directly influence the brain, there is an urgent need to study the synergy of combined techniques. Non-invasive brain stimulation (NIBS) as a direct neuromodulatory intervention has the potential to act synergistically with CIMT to influence neurorecovery. Combining behavioral therapies, constraint-induced movement therapy (CIMT), with a novel form of neuromodulation, transcranial direct current stimulation (tDCS), we investigated the influence of this intervention on improved motor outcomes in children with cerebral palsy. The study hypotheses surround the safety, feasibility and efficacy of combined CIMT and tDCS wherein those children who receive the combined intervention will reveal no major adverse events, yet improved hand function and cortical excitability. To Note: In addition to the combination of NIBS with CIMT, we also investigated the combination of NIBS with another form of motor intervention, bimanual, or two-handed, training. During bimanual training, children engage both hands in movements. The goal of bimanual training is to teach children how to most effectively use their hands cooperatively. During bimanual training, children play with games and toys that require the use of both hands. Children also practice activities of daily living that require the use of both hands, such as putting hair in a ponytail, tying shoes, and buttoning clothing. N=8 for this pilot study and no randomization. (Burke Medical Research Institute partnered with Columbia University and did a parallel pilot study. N=8 (PIs Friel and Gordon; Protocol BRC449)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2014

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 26, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

December 31, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2017

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2017

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

August 18, 2020

Completed
Last Updated

August 18, 2020

Status Verified

August 1, 2020

Enrollment Period

2.5 years

First QC Date

September 18, 2014

Results QC Date

December 9, 2019

Last Update Submit

August 6, 2020

Conditions

Keywords

Cerebral PalsyHemiparesisStrokeNon-Invasive Brain StimulationTranscranial Direct Current StimulationConstraint-Induced Movement TherapyDiffusion Tensor ImagingCongenital HemiparesisBimanual Therapy

Outcome Measures

Primary Outcomes (1)

  • Change in Assisting Hand Assessment (AHA)

    Participants were videotaped while performing a bimanual age-appropriate activity. Investigators scored this performance using the Assessment of Assisting Hand (AHA) inventory. The AHA consists of 22 items, each scored on a 4-point scale. Raw scores are a sum of the 22 item scores, ranging from 22-88. Computer software logarithmically transforms ordinal raw scores into a final score. Final scores are reported on a logit-based AHA-unit scale and range from 0 to 100, with higher scores indicating greater ability. Outcome is reported as the change from baseline to 2 weeks and change from baseline to 6 months.

    2 weeks, 6 months

Secondary Outcomes (1)

  • Change in Canadian Occupational Performance Measurement (COPM)

    2 weeks, 6 months

Other Outcomes (1)

  • Change in Subject Symptom Assessment (SSA) From 2 Weeks to 6 Months

    2 weeks, 6 months

Study Arms (2)

tDCS/CIMT

ACTIVE COMPARATOR

Intervention Group will receive 20 minutes of 1.0 mA tDCS to the contralesional hemisphere concurrent with CIMT.

Device: Transcranial Direct Current Stimulation (tDCS)

tDCS sham/CIMT

PLACEBO COMPARATOR

Placebo Group will receive 20 minutes of sham 1.0 mA tDCS to the contralesional hemisphere concurrent with CIMT.

Device: Placebo Comparator

Interventions

10 tDCS/CIMT Sessions

Also known as: tDCS, Brain Stimulation
tDCS/CIMT
tDCS sham/CIMT

Eligibility Criteria

Age8 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Hemispheric Stroke or Periventricular Leukomalacia confirmed by most recent MRI or CT radiologic report with resultant congenital hemiparesis
  • ≥ 10 degrees of active motion at the metacarpophalangeal joint
  • Receptive language function to follow two-step commands as evidenced by performance on TOKEN test of intelligence
  • No evidence of seizure activity within the last 2 years
  • Presence of a motor evoked potential from at least the contralesional hemisphere if not both hemispheres
  • Ages 8-21 years
  • Able to give informed assent along with the informed consent of the legal guardian
  • Children who have had surgeries, which may influence motor function eg- tendon transfer, will be included, yet surgical history will be documented and included in any publication within a participant characteristics table.

You may not qualify if:

  • Metabolic Disorders
  • Neoplasm
  • Epilepsy
  • Disorders of Cellular Migration and Proliferation
  • Acquired Traumatic Brain Injury
  • Pregnancy
  • Indwelling metal or incompatible medical devices
  • Evidence of skin disease or skin abnormalities
  • Botulinum toxin or Phenol block within \[six-months\] preceding the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

Gillette Children's Specialty Healthcare

Saint Paul, Minnesota, 55101, United States

Location

Related Publications (2)

  • Gillick B, Menk J, Mueller B, Meekins G, Krach LE, Feyma T, Rudser K. Synergistic effect of combined transcranial direct current stimulation/constraint-induced movement therapy in children and young adults with hemiparesis: study protocol. BMC Pediatr. 2015 Nov 12;15:178. doi: 10.1186/s12887-015-0498-1.

    PMID: 26558386BACKGROUND
  • Lixandrao MC, Stinear JW, Rich T, Chen CY, Feyma T, Meekins GD, Gillick BT. EMG breakthrough during cortical silent period in congenital hemiparesis: a descriptive case series. Braz J Phys Ther. 2020 Jan-Feb;24(1):20-29. doi: 10.1016/j.bjpt.2018.11.002. Epub 2018 Nov 22.

MeSH Terms

Conditions

Cerebral PalsyParesisStroke

Interventions

Transcranial Direct Current StimulationDeep Brain Stimulation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesSurgical Procedures, Operative

Results Point of Contact

Title
Bernadette Gillick
Organization
University of Minnesota

Study Officials

  • Bernadette T Gillick, PhD, MSPT, PT

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2014

First Posted

September 26, 2014

Study Start

December 31, 2014

Primary Completion

June 28, 2017

Study Completion

July 10, 2017

Last Updated

August 18, 2020

Results First Posted

August 18, 2020

Record last verified: 2020-08

Locations